방사선생물학

본문글자크기
  • MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B.

    (동남권원자력의학원, 허K) Park SJ, Shim JW, Park HS, Eum DY, Park MT, Mi Yi J, Choi SH, Kim SD, Son TG, Lu W, Kim ND, Yang K, Heo K.

  • 출처
    Oncogene.
  • 등재일
    2015 Jun 1
  • 저널이슈번호
    doi: 10.1038/onc.2015.187. [Epub ahead of print]
  • 내용

    바로가기  >

    [Abstract]

    The histone variant, macroH2A1, has an important role in embryonic stem cell differentiation and tumor progression in various types of tumors. However, the regulatory roles of macroH2A1 on bladder cancer progression have not been fully elucidated. Here, we show that macroH2A1 knockdown promotes stem-like properties of bladder cancer cells. The knockdown of macroH2A1 in bladder cancer cells increased tumorigenicity, radioresistance, degeneration of reactive oxygen species, increased sphere formation capability and an increase in the proportion of side populations. We found that macroH2A1 is required for the suppression of Lin28B identified as a novel downstream target of macroH2A1 in bladder cancer. Loss of macroH2A1 expression significantly correlated with the elevated levels of Lin28B expression and subsequently inhibited the mature let-7 microRNA expression. Furthermore, the stable overexpression of Lin28B enhances the several phenotypes, including tumorigenicity and sphere-forming ability, which are induced by macroH2A1 depletion. Importantly, Lin28B expression was regulated by macroH2A1-mediated reciprocal binding of p300 and EZH2/SUV39H1. Our results suggest that Lin28B/let-7 pathway is tightly regulated by macroH2A1 and its cofactors, and have a pivotal role in the bladder tumor progression and the regulation of stem-like characteristics of bladder cancer cells.Oncogene advance online publication, 1 June 2015; doi:10.1038/onc.2015.187.

     

    [Author information]

    Park SJ1, Shim JW2, Park HS2, Eum DY2, Park MT2, Mi Yi J2, Choi SH2, Kim SD2, Son TG2, Lu W3, Kim ND4, Yang K5, Heo K2.

    1 1] Research Center, Dongnam Institute of Radiological and Medical Science (DIRAMS), Busan, Republic of Korea [2] Department of Pharmacy, Pusan National University, Busan, Republic of Korea.

    2 Research Center, Dongnam Institute of Radiological and Medical Science (DIRAMS), Busan, Republic of Korea.

    3 The Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, CA, USA.

    4 Department of Pharmacy, Pusan National University, Busan, Republic of Korea.

    5 1] Research Center, Dongnam Institute of Radiological and Medical Science (DIRAMS), Busan, Republic of Korea [2] Department of Radiation Oncology, Dongnam Institute of Radiological & Medical Sciences, Busan, Republic of Korea [3] Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.

     

  • 덧글달기
    덧글달기
       IP : 18.234.232.228

    등록